164 related articles for article (PubMed ID: 23625387)
1. Increased expression of aldehyde dehydrogenase 1 A1 in nasopharyngeal carcinoma is associated with enhanced invasiveness.
Hou W; He W; Li Y; Ma R; Wang Z; Zhu X; Fu Q; Wen Y; Li H; Wen W
Eur Arch Otorhinolaryngol; 2014 Jan; 271(1):171-9. PubMed ID: 23625387
[TBL] [Abstract][Full Text] [Related]
2. Aldehyde dehydrogenase 1 A1-positive cell population is enriched in tumor-initiating cells and associated with progression of bladder cancer.
Su Y; Qiu Q; Zhang X; Jiang Z; Leng Q; Liu Z; Stass SA; Jiang F
Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):327-37. PubMed ID: 20142235
[TBL] [Abstract][Full Text] [Related]
3. Aldehyde dehydrogenase 1A1 possesses stem-like properties and predicts lung cancer patient outcome.
Li X; Wan L; Geng J; Wu CL; Bai X
J Thorac Oncol; 2012 Aug; 7(8):1235-45. PubMed ID: 22617249
[TBL] [Abstract][Full Text] [Related]
4. NOR1 Suppresses Cancer Stem-Like Cells Properties of Tumor Cells via the Inhibition of the AKT-GSK-3β-Wnt/β-catenin-ALDH1A1 Signal Circuit.
Wang W; Yi M; Chen S; Li J; Zhang H; Xiong W; Li G; Li X; Xiang B
J Cell Physiol; 2017 Oct; 232(10):2829-2840. PubMed ID: 27891591
[TBL] [Abstract][Full Text] [Related]
5. Inflammation-Related DNA Damage and Cancer Stem Cell Markers in Nasopharyngeal Carcinoma.
Wang S; Ma N; Zhao W; Midorikawa K; Kawanishi S; Hiraku Y; Oikawa S; Zhang Z; Huang G; Murata M
Mediators Inflamm; 2016; 2016():9343460. PubMed ID: 27647953
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of stem cell markers ALDH1A1 and OCT4 as potential biomarkers for the early detection of cervical carcinoma.
Tulake W; Yuemaier R; Sheng L; Ru M; Lidifu D; Abudula A
Oncol Lett; 2018 Nov; 16(5):5525-5534. PubMed ID: 30344706
[TBL] [Abstract][Full Text] [Related]
7. ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome.
Li T; Su Y; Mei Y; Leng Q; Leng B; Liu Z; Stass SA; Jiang F
Lab Invest; 2010 Feb; 90(2):234-44. PubMed ID: 20010854
[TBL] [Abstract][Full Text] [Related]
8. Distinct patterns of ALDH1A1 expression predict metastasis and poor outcome of colorectal carcinoma.
Xu SL; Zeng DZ; Dong WG; Ding YQ; Rao J; Duan JJ; Liu Q; Yang J; Zhan N; Liu Y; Hu QP; Zhang X; Cui YH; Kung HF; Yu SC; Bian XW
Int J Clin Exp Pathol; 2014; 7(6):2976-86. PubMed ID: 25031716
[TBL] [Abstract][Full Text] [Related]
9. Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling.
Sullivan JP; Spinola M; Dodge M; Raso MG; Behrens C; Gao B; Schuster K; Shao C; Larsen JE; Sullivan LA; Honorio S; Xie Y; Scaglioni PP; DiMaio JM; Gazdar AF; Shay JW; Wistuba II; Minna JD
Cancer Res; 2010 Dec; 70(23):9937-48. PubMed ID: 21118965
[TBL] [Abstract][Full Text] [Related]
10. NEK2 mediates ALDH1A1-dependent drug resistance in multiple myeloma.
Yang Y; Zhou W; Xia J; Gu Z; Wendlandt E; Zhan X; Janz S; Tricot G; Zhan F
Oncotarget; 2014 Dec; 5(23):11986-97. PubMed ID: 25230277
[TBL] [Abstract][Full Text] [Related]
11. Cancer stem cell characteristics, ALDH1 expression in the invasive front of nasopharyngeal carcinoma.
Luo WR; Yao KT
Virchows Arch; 2014 Jan; 464(1):35-43. PubMed ID: 24248285
[TBL] [Abstract][Full Text] [Related]
12. Low expression of aldehyde dehydrogenase 1A1 (ALDH1A1) is a prognostic marker for poor survival in pancreatic cancer.
Kahlert C; Bergmann F; Beck J; Welsch T; Mogler C; Herpel E; Dutta S; Niemietz T; Koch M; Weitz J
BMC Cancer; 2011 Jun; 11():275. PubMed ID: 21708005
[TBL] [Abstract][Full Text] [Related]
13. Over-expression of eukaryotic translation initiation factor 4 gamma 1 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma.
Tu L; Liu Z; He X; He Y; Yang H; Jiang Q; Xie S; Xiao G; Li X; Yao K; Fang W
Mol Cancer; 2010 Apr; 9():78. PubMed ID: 20398343
[TBL] [Abstract][Full Text] [Related]
14. Cripto-1 overexpression is involved in the tumorigenesis of nasopharyngeal carcinoma.
Wu Z; Li G; Wu L; Weng D; Li X; Yao K
BMC Cancer; 2009 Sep; 9():315. PubMed ID: 19732464
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of ALDH1A1 protein is associated with poor prognosis in clear cell renal cell carcinoma.
Wang K; Chen X; Zhan Y; Jiang W; Liu X; Wang X; Wu B
Med Oncol; 2013; 30(2):574. PubMed ID: 23585015
[TBL] [Abstract][Full Text] [Related]
16. Far upstream element-binding protein 1 is a prognostic biomarker and promotes nasopharyngeal carcinoma progression.
Liu ZH; Hu JL; Liang JZ; Zhou AJ; Li MZ; Yan SM; Zhang X; Gao S; Chen L; Zhong Q; Zeng MS
Cell Death Dis; 2015 Oct; 6(10):e1920. PubMed ID: 26469968
[TBL] [Abstract][Full Text] [Related]
17. Targeting ALDH(bright) human carcinoma-initiating cells with ALDH1A1-specific CD8⁺ T cells.
Visus C; Wang Y; Lozano-Leon A; Ferris RL; Silver S; Szczepanski MJ; Brand RE; Ferrone CR; Whiteside TL; Ferrone S; DeLeo AB; Wang X
Clin Cancer Res; 2011 Oct; 17(19):6174-84. PubMed ID: 21856769
[TBL] [Abstract][Full Text] [Related]
18. ALDH1A1 is a marker of astrocytic differentiation during brain development and correlates with better survival in glioblastoma patients.
Adam SA; Schnell O; Pöschl J; Eigenbrod S; Kretzschmar HA; Tonn JC; Schüller U
Brain Pathol; 2012 Nov; 22(6):788-97. PubMed ID: 22417385
[TBL] [Abstract][Full Text] [Related]
19. Effects of ellipticine on ALDH1A1-expressing breast cancer stem cells--an in vitro and in silico study.
Pandrangi SL; Chikati R; Chauhan PS; Kumar CS; Banarji A; Saxena S
Tumour Biol; 2014 Jan; 35(1):723-37. PubMed ID: 23982874
[TBL] [Abstract][Full Text] [Related]
20. ALDH1A1 defines invasive cancer stem-like cells and predicts poor prognosis in patients with esophageal squamous cell carcinoma.
Yang L; Ren Y; Yu X; Qian F; Bian BS; Xiao HL; Wang WG; Xu SL; Yang J; Cui W; Liu Q; Wang Z; Guo W; Xiong G; Yang K; Qian C; Zhang X; Zhang P; Cui YH; Bian XW
Mod Pathol; 2014 May; 27(5):775-83. PubMed ID: 24201124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
